Sep 15, 2025, 08:26
Subcutaneous Prophylaxis for Hemophilia (With or Without Inhibitors) – Novo Nordisk and HFA Webinar
Hemophilia Federation of America (HFA) has shared a post on LinkedIn:
“Join Novo Nordisk and HFA for a special presentation:
‘A New Subcutaneous Prophylaxis Treatment for Hemophilia With and Without Inhibitors.’
Learn about the clinical study, safety and efficacy
Explore an innovative mechanism of action
See the unique prefilled injection pen design
Don’t miss it—mark your calendar and sign up today! ”
You can sign up here.
Discover more on Hemostasis Today.
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism